Which closed-end funds own Ionis Pharmaceuticals Inc?
14 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $41M. Security type: debt security. Country: United States. CUSIP 462222AG5 · ISIN US462222AG55.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BCV Bancroft Fund | U.S. Equity | 2.22% | $4.2M | 3,977,000 par | $192M | 12.1% discount | Jun 30, 2026 |
| GCV Gabelli Convertible & Income Securities Fund | Convertible Securities | 1.91% | $1.9M | 1,739,000 par | $97.4M | 3.4% discount | Jun 30, 2026 |
| ECF Ellsworth Growth & Income Fund | U.S. Equity | 1.82% | $4.2M | 3,977,000 par | $233M | 10.9% discount | Jun 30, 2026 |
| CCD Calamos Dynamic Convertible & Income Fund | Convertible Securities | 0.73% | $6.9M | 7,750,000 par | $939M | 6.7% premium | Jul 31, 2026 |
| CHY Calamos Convertible & High Income Fund | Convertible Securities | 0.61% | $8.9M | 10,000,000 par | $1.5B | 0.3% premium | Jul 31, 2026 |
| CHI Calamos Convertible Opportunities & Income Fund | Convertible Securities | 0.60% | $8.2M | 9,250,000 par | $1.4B | 4.5% premium | Jul 31, 2026 |
| AVK Advent Convertible & Income Fund | Convertible Securities | 0.29% | $2.2M | 2,478,000 par | $757M | NAV unavailable | Jul 31, 2026 |
| NCZ Virtus Convertible & Income Fund II | Convertible Securities | 0.18% | $852K | 965,000 par | $463M | 7.6% discount | Jul 31, 2026 |
| NCV Virtus Convertible & Income Fund | Convertible Securities | 0.18% | $1.1M | 1,215,000 par | $601M | 9.6% discount | Jul 31, 2026 |
| ACV Virtus Diversified Income & Convertible Fund | Convertible Securities | 0.17% | $636K | 720,000 par | $380M | 5.3% discount | Jul 31, 2026 |
| NIE Virtus Equity & Convertible Income Fund | Convertible Securities | 0.11% | $848K | 960,000 par | $786M | 9.5% discount | Jul 31, 2026 |
| PIM Franklin Master Intermediate Income Trust | Investment Grade | 0.06% | $117K | 110,000 par | $199M | 8.9% discount | Jun 30, 2026 |
| NFJ Virtus Dividend, Interest & Premium Strategy Fund | U.S. Equity | 0.06% | $839K | 950,000 par | $1.5B | 9.0% discount | Jul 31, 2026 |
| PPT Franklin Premier Income Trust | Taxable Bonds | 0.05% | $212K | 239,000 par | $390M | 9.6% discount | Jul 31, 2026 |
14 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: IONIS PHARMACEUTICALS IN; Ionis Pharmaceuticals, Inc..
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Ionis Pharmaceuticals Inc | common equity | 8 |
| Ionis Pharmaceuticals Inc | debt security | 1 |
Issuer-level search for “IONIS PHARMACEUTICALS INC” → · Compare two funds’ portfolios →